391 related articles for article (PubMed ID: 25387803)
1. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.
Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG
Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803
[TBL] [Abstract][Full Text] [Related]
2. Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.
Plengpanich W; Young SG; Khovidhunkit W; Bensadoun A; Karnman H; Ploug M; Gårdsvoll H; Leung CS; Adeyo O; Larsson M; Muanpetch S; Charoen S; Fong LG; Niramitmahapanya S; Beigneux AP
J Biol Chem; 2014 Jul; 289(28):19491-9. PubMed ID: 24847059
[TBL] [Abstract][Full Text] [Related]
3. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
Beigneux AP; Franssen R; Bensadoun A; Gin P; Melford K; Peter J; Walzem RL; Weinstein MM; Davies BS; Kuivenhoven JA; Kastelein JJ; Fong LG; Dallinga-Thie GM; Young SG
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):956-62. PubMed ID: 19304573
[TBL] [Abstract][Full Text] [Related]
4. Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.
Voss CV; Davies BS; Tat S; Gin P; Fong LG; Pelletier C; Mottler CD; Bensadoun A; Beigneux AP; Young SG
Proc Natl Acad Sci U S A; 2011 May; 108(19):7980-4. PubMed ID: 21518912
[TBL] [Abstract][Full Text] [Related]
5. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.
Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144
[TBL] [Abstract][Full Text] [Related]
6. GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
Young SG; Davies BS; Voss CV; Gin P; Weinstein MM; Tontonoz P; Reue K; Bensadoun A; Fong LG; Beigneux AP
J Lipid Res; 2011 Nov; 52(11):1869-84. PubMed ID: 21844202
[TBL] [Abstract][Full Text] [Related]
7. Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells.
Gin P; Beigneux AP; Voss C; Davies BS; Beckstead JA; Ryan RO; Bensadoun A; Fong LG; Young SG
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):176-82. PubMed ID: 20966398
[TBL] [Abstract][Full Text] [Related]
8. Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding.
Allan CM; Jung CJ; Larsson M; Heizer PJ; Tu Y; Sandoval NP; Dang TLP; Jung RS; Beigneux AP; de Jong PJ; Fong LG; Young SG
J Lipid Res; 2017 Jul; 58(7):1453-1461. PubMed ID: 28476858
[TBL] [Abstract][Full Text] [Related]
9. Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase.
Beigneux AP; Davies BS; Tat S; Chen J; Gin P; Voss CV; Weinstein MM; Bensadoun A; Pullinger CR; Fong LG; Young SG
J Biol Chem; 2011 Jun; 286(22):19735-43. PubMed ID: 21478160
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.
Rabacchi C; D'Addato S; Palmisano S; Lucchi T; Bertolini S; Calandra S; Tarugi P
J Clin Lipidol; 2016; 10(4):915-921.e4. PubMed ID: 27578123
[TBL] [Abstract][Full Text] [Related]
11. A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism.
Young SG; Song W; Yang Y; Birrane G; Jiang H; Beigneux AP; Ploug M; Fong LG
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2211136119. PubMed ID: 36037340
[TBL] [Abstract][Full Text] [Related]
12. GPIHBP1 and Plasma Triglyceride Metabolism.
Fong LG; Young SG; Beigneux AP; Bensadoun A; Oberer M; Jiang H; Ploug M
Trends Endocrinol Metab; 2016 Jul; 27(7):455-469. PubMed ID: 27185325
[TBL] [Abstract][Full Text] [Related]
13. Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis.
Birrane G; Beigneux AP; Dwyer B; Strack-Logue B; Kristensen KK; Francone OL; Fong LG; Mertens HDT; Pan CQ; Ploug M; Young SG; Meiyappan M
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1723-1732. PubMed ID: 30559189
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL.
Hu X; Sleeman MW; Miyashita K; Linton MF; Allan CM; He C; Larsson M; Tu Y; Sandoval NP; Jung RS; Mapar A; Machida T; Murakami M; Nakajima K; Ploug M; Fong LG; Young SG; Beigneux AP
J Lipid Res; 2017 Jan; 58(1):208-215. PubMed ID: 27875259
[TBL] [Abstract][Full Text] [Related]
15. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
[TBL] [Abstract][Full Text] [Related]
16. Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase.
Beigneux AP; Gin P; Davies BS; Weinstein MM; Bensadoun A; Fong LG; Young SG
J Biol Chem; 2009 Oct; 284(44):30240-7. PubMed ID: 19726683
[TBL] [Abstract][Full Text] [Related]
17. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.
Franssen R; Young SG; Peelman F; Hertecant J; Sierts JA; Schimmel AW; Bensadoun A; Kastelein JJ; Fong LG; Dallinga-Thie GM; Beigneux AP
Circ Cardiovasc Genet; 2010 Apr; 3(2):169-78. PubMed ID: 20124439
[TBL] [Abstract][Full Text] [Related]
18. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.
Olivecrona G; Ehrenborg E; Semb H; Makoveichuk E; Lindberg A; Hayden MR; Gin P; Davies BS; Weinstein MM; Fong LG; Beigneux AP; Young SG; Olivecrona T; Hernell O
J Lipid Res; 2010 Jun; 51(6):1535-45. PubMed ID: 20026666
[TBL] [Abstract][Full Text] [Related]
19. Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1.
Gin P; Goulbourne CN; Adeyo O; Beigneux AP; Davies BS; Tat S; Voss CV; Bensadoun A; Fong LG; Young SG
Hum Mol Genet; 2012 Jul; 21(13):2961-72. PubMed ID: 22493000
[TBL] [Abstract][Full Text] [Related]
20. An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.
Allan CM; Larsson M; Hu X; He C; Jung RS; Mapar A; Voss C; Miyashita K; Machida T; Murakami M; Nakajima K; Bensadoun A; Ploug M; Fong LG; Young SG; Beigneux AP
J Lipid Res; 2016 Oct; 57(10):1889-1898. PubMed ID: 27494936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
